ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,144,808 | +7.4% | 140,376 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $12,240,193 | +50.2% | 137,145 | +80.5% | 0.00% | 0.0% |
| Q1 2023 | $8,148,000 | +86830.5% | 75,997 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $9,373 | -99.9% | 76,744 | -15.8% | 0.00% | 0.0% |
| Q3 2022 | $9,410,000 | -18.5% | 91,119 | -26.6% | 0.00% | -50.0% |
| Q2 2022 | $11,546,000 | +423.2% | 124,211 | +560.4% | 0.00% | – |
| Q1 2022 | $2,207,000 | -5.0% | 18,809 | +8.9% | 0.00% | – |
| Q4 2021 | $2,324,000 | +109.2% | 17,279 | +148.2% | 0.00% | – |
| Q3 2021 | $1,111,000 | +45.8% | 6,962 | +20.3% | 0.00% | – |
| Q2 2021 | $762,000 | -86.7% | 5,789 | -87.0% | 0.00% | -100.0% |
| Q1 2021 | $5,733,000 | +305.7% | 44,488 | +425.1% | 0.00% | – |
| Q4 2020 | $1,413,000 | -83.7% | 8,472 | -85.1% | 0.00% | -100.0% |
| Q3 2020 | $8,661,000 | +49.1% | 56,883 | +44.8% | 0.00% | 0.0% |
| Q2 2020 | $5,809,000 | +43.8% | 39,272 | +9.5% | 0.00% | 0.0% |
| Q1 2020 | $4,039,000 | +59.8% | 35,870 | +97.5% | 0.00% | – |
| Q4 2019 | $2,527,000 | +263.1% | 18,165 | +151.4% | 0.00% | – |
| Q3 2019 | $696,000 | -87.5% | 7,225 | -86.0% | 0.00% | -100.0% |
| Q2 2019 | $5,581,000 | +46.7% | 51,484 | +59.3% | 0.00% | 0.0% |
| Q1 2019 | $3,804,000 | +6240.0% | 32,324 | +3693.9% | 0.00% | – |
| Q3 2018 | $60,000 | -76.5% | 852 | -78.1% | 0.00% | – |
| Q1 2018 | $255,000 | -96.4% | 3,899 | -98.1% | 0.00% | -100.0% |
| Q3 2017 | $7,163,000 | – | 201,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |